{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:49:55Z","timestamp":1790776195913,"version":"4.1.0"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,16]]},"DOI":"10.18632\/oncotarget.16145","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T06:03:44Z","timestamp":1489385024000},"page":"33110-33121","source":"Crossref","is-referenced-by-count":61,"title":["NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Ya","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chundong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[{"name":"First Clinical College, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaina","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huo","sequence":"additional","affiliation":[{"name":"College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youquan","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China"},{"name":"Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"He","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Kaye","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","article-title":"Epithelial-mesenchymal transitions: twist in development and metastasis","volume":"118","author":"Massagu\u00e9","year":"2004","journal-title":"Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Thiery","year":"2016","journal-title":"Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"7","first-page":"33","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Reich","year":"2012","journal-title":"Front Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Salzet","year":"2010","journal-title":"Cancer Lett"},{"key":"9","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00018-010-0367-x","article-title":"Basement membrane components are key players in specialized extracellular matrices","volume":"67","author":"Miosge","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10","doi-asserted-by":"crossref","first-page":"a004911","DOI":"10.1101\/cshperspect.a004911","article-title":"Basement membranes: cell scaffoldings and signaling platforms","volume":"3","author":"Yurchenco","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bies.950180208","article-title":"Supramolecular assembly of basement membranes","volume":"18","author":"Brown","year":"1996","journal-title":"BioEssays"},{"key":"12","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/pmic.201100654","article-title":"The ovarian cancer-derived secretory\/releasing proteome: A repertoire of tumor markers","volume":"12","author":"Wang","year":"2012","journal-title":"Proteomics"},{"key":"13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jjco\/hyu187","article-title":"Nidogen-1: a candidate biomarker for ovarian serous cancer","volume":"45","author":"Wu","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.febslet.2006.03.033","article-title":"Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo","volume":"580","author":"Park","year":"2006","journal-title":"FEBS Lett"},{"key":"15","doi-asserted-by":"crossref","first-page":"18802","DOI":"10.1016\/S0021-9258(18)55134-6","article-title":"Potential role of entactin in hemostasis. Specific interaction of entactin with fibrinogen A alpha and B beta chains","volume":"266","author":"Chung","year":"1991","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.matbio.2009.09.004","article-title":"Impaired wound healing in mice lacking the basement membrane protein nidogen 1","volume":"29","author":"Nischt","year":"2010","journal-title":"Matrix Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10585-015-9720-7","article-title":"Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion","volume":"32","author":"Castellv\u00ed","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"18","doi-asserted-by":"crossref","first-page":"e103988","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Helleman","year":"2014","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Hung","year":"2008","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Hartmann","year":"2011","journal-title":"Nature"},{"key":"21","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Saksena","year":"2013","journal-title":"J Clin Invest"},{"key":"22","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","article-title":"A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer","volume":"68","author":"Birrer","year":"2008","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1158\/0008-5472.CAN-12-1033","article-title":"TWIST1 is an ERK1\/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells","volume":"72","author":"Aplin","year":"2012","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-10-2914","article-title":"Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness","volume":"71","author":"Xu","year":"2011","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0270","article-title":"Akt\/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K\/Akt and TGF-\u03b2 signaling axes","volume":"2","author":"Hemmings","year":"2012","journal-title":"Cancer Discov"},{"key":"26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1365-2133.2012.10824.x","article-title":"Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K\/PTEN pathway through Twist and Snail","volume":"166","author":"Persad","year":"2012","journal-title":"Br J Dermatol"},{"key":"27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/1471-2407-13-549","article-title":"Identification of the IGF1\/PI3K\/NF \u03baB\/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer","volume":"13","author":"Squire","year":"2013","journal-title":"BMC Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Thiery","year":"2014","journal-title":"EMBO Mol Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Schlaepfer","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1016\/S0021-9258(19)37047-4","article-title":"The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3\/beta 1","volume":"267","author":"Gray","year":"1992","journal-title":"J Biol Chem"},{"key":"31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"32","first-page":"389","article-title":"A systems biology case study of ovarian cancer drug resistance","volume":"5","author":"Wang","year":"2006","journal-title":"Comput Syst Bioinformatics Conf"},{"key":"33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s13402-016-0308-2","article-title":"HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K\/AKT pathway activation","volume":"40","author":"Manavathi","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"key":"34","first-page":"37","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer","volume":"37","author":"Huang","year":"2017","journal-title":"Biosci Rep"},{"key":"35","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1007\/s13277-016-4848-x","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer","volume":"37","author":"Sun","year":"2016","journal-title":"Tumour Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chou","year":"2015","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10555-012-9345-0","article-title":"Cancer stem cells and EMT in carcinoma","volume":"31","author":"Mackenzie","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biocel.2012.12.002","article-title":"PRR11 is a novel gene implicated in cell cycle progression and lung cancer","volume":"45","author":"Bu","year":"2013","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T21:09:46Z","timestamp":1658783386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":38,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5,16]]}},"alternative-id":["16145","28416770"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16145","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}